key: cord-0810503-260ic5hs
authors: Laguna, Ma Luisa Bordejé; Marcos-Neira, Pilar; de Lagrán Zurbano, Itziar Martínez; Marco, Esther Mor; Guisasola, Carlos Pollán; Viñas Soria, Constanza Dolores; Martí, Pilar Ricart
title: Dysphagia And Mechanical Ventilation In Sars-Cov-2 Pneumonia: It’s Real
date: 2021-11-23
journal: Clin Nutr
DOI: 10.1016/j.clnu.2021.11.018
sha: 2813c45f988654d0debbfca34871d1b04bb8ea9f
doc_id: 810503
cord_uid: 260ic5hs

Background And Aim Dysphagia can be a consequence of prolonged hospitalization in intensive care units (ICUs) due to severe SARS-CoV-2 pneumonia. This study aims at Identifying the risk factors for dysphagia in ICU patients with COVID-19 pneumonia requiring invasive mechanical ventilation, and at determining the frequency of postextubation dysphagia in this population. Methods Observational, descriptive, retrospective, cohort study of SARS-CoV-2 pneumonia patients admitted into the ICUs from March to May 2020. The Modified Viscosity Volume Swallowing Test (mV-VST) was used to screening for dysphagia during the first 48 hours of extubation in patients requiring mechanical ventilation. Descriptive statistics, univariate and multivariate analyses were conducted. A logistic regression was applied to construct a predictive model of dysphagia. Results A total of 232 patients were admitted into the ICUs (age [median 60.5 years (95% CI: 58.5 to 61.9)]; male [74.1% (95% CI: 68.1 to 79.4)]; APACHE II score [median 17.7 (95% CI: 13.3 to 23.2)]; length of mechanical ventilation [median 14 days (95% CI: 11 to 16)]; prone position [79% (95% CI: 72.1 to 84.6)]; respiratory infection [34.5% (95% CI: 28.6 to 40.9)], renal failure [38.5% (95% CI: 30 to 50)])). 72% (167) of patients required intubation; 65.9% (110) survived; and in 84.5% (93) the mV-VST was performed. Postextubation dysphagia was diagnosed in 26.9% (25) of patients. APACHE II, prone position, length of ICU and hospital stay, length of mechanical ventilation, tracheostomy, respiratory infection and kidney failure developed during admission were significantly associated (p<0.05) with dysphagia. Dysphagia was independently explained by the APACHE II score (OR: 1.1; 95% CI: 1.01 to 1.3; p=0.04) and tracheostomy (OR: 10.2; 95% CI: 3.2 to 32.1) p<0.001). The predictive model forecasted dysphagia with a good ROC curve (AUC: 0.8; 95% CI: 0.7 to 0.9). Conclusions Dysphagia affects almost one-third of patients with SARS-COV-2 pneumonia requiring intubation in the ICU. The risk of developing dysphagia increases with prolonged mechanical ventilation, tracheostomy, and poorer prognosis on admission (worst APACHE II score).

Modified Viscosity Volume Swallowing Test (mV-VST) 117 The mV-VST is based on the swallowing of nectar, pudding and liquid viscosities (21) 118 (22). These viscosities are achieved by mixing mineral water with the dose of a thickener 119 indicated by the manufacturer; in this study, the thickener Nutilis Clear® (Nutricia) was 120 used (23). Viscosities were stained with blue food coloring to visualize pulmonary 121 aspiration. Before starting the mV-VST, the patient was asked to say his or her name to 122 identify the tone of voice. The mV-VST begun with the nectar viscosity. Increasing 123 volumes of 5, 10 and 15 mL were consecutively placed in the patient's mouth with a 50-124 mL syringe. The following safety parameters were assessed each time: presence of cough, 125 desaturation > 3%, change in the tone of voice by asking the patient to repeat his/her 126 name, and presence of pharyngeal residue by asking the patient whether he/she has the 127 sensation of food remaining in the pharyngeal area. If there was no alteration in any of 128 the safety parameters, the same assessment was progressively performed with the 129 pudding-and liquid-viscosity volumes, respectively. Dysphagia and risk of aspiration 130 were discarded only in those patients safely swallowing all tested viscosities. In case a 131 single safety parameter was altered, the evaluation of that viscosity was suspended. The 132 patient was rendered as having dysphagia and no oral intake was allowed provided the 133 high risk of pulmonary aspiration. The mV-VST process is shown in Figure 1 . extubated and prior to starting oral intake as per the ICU protocol. In patients with a 137 fenestrated tracheostomy tube, the mV-VST was done using the fenestrated inner cannula 138 and a deflated cuff. The study power to identify risk factors for dysphagia was calculated based on the 232 155 critically ill patients with COVID-19 pneumonia who were admitted to our hospital 156 during the first wave of the pandemic. Considering an estimated 13.3% incidence of were diagnosed with postextubation dysphagia (Figure 2 

ICU-acquired swallowing disorders

The authors declare no conflict of interest